Data Presented at AACR 2023 Highlights Exscientia's Clinical and Preclinical Development
- Includes recent advancements from precision designed compounds - - Functional personalised medicine platform unveiling unique adenosine biomarker to enrich for patients more likely to respond to... | April 19, 2023